Published online before print July 28, 2005, doi: 10.1161/01.ATV.0000179675.49619.9b
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 American Heart Association, Inc.
Vascular Biology |
Mechanisms of the Inhibitory Effect of Epigallocatechin-3-Gallate on Cultured Human Vascular Smooth Muscle Cell Invasion
From the Departments of Geriatrics (X.W.C., M.K., K.N., Z.L., Q.D., J.H., M.I., A.I.), Cardiovascular Genome Science (X.W.C., M.Y.), and Cardiology (T.M.), Nagoya University Graduate School of Medicine, and the Cardiovascular Department (X.W.C.), College of Medical, Yanbian University, 119 Juzijie, Yanji, Jilin Province, China.
Correspondence to Masafumi Kuzuya, MD, PhD, Department of Geriatrics, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. E-mail kuzuya{at}med.nagoya-u.ac.jp
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Objective— Although we recently showed that the administration of catechins reduced the neointimal formation in a rat balloon-injury model, the precise molecular mechanisms are largely unknown. In the present study, we tried to determine these mechanisms using an in vitro SMC invasion system.
Methods and Results— Boyden chamber assay was used to examine the effect of catechins on the invasive behavior of SMCs. The invasive activity of SMCs through collagen gel was restrained by EGCG in a concentration-dependent manner. The data from gelatin and collagen zymography and Western blot revealed that EGCG blocks the activation of pro-matrix metalloproteinase (MMP)-2 during an invasion assay and in the conditioned medium of cultured SMCs as well as the activities of MMP-2 and membrane type 1-MMP (MT1-MMP) even at 0.1 to 0.3 µmol/L of EGCG. EGCG was found to restrain MT1-MMPcat–dependent pro–MMP-2 activation. EGCG upregulated the expression of tissue inhibitor of MMP-2 (TIMP-2) protein. Reverse zymography showed that the increased TIMP-2 to expression was validated by an increased activity. The data from decreased TIMP-2 activity using its siRNA suggested that upregulation of TIMP-2 expression may be one of the major mechanisms for inhibition of SMC invasion by EGCG.
Conclusions— These results indicate that EGCG targets multiple MMP-mediated SMC cellular events and provides a new major mechanism for the SMC invasion through upregulation of TIMP-2 expression to modulate MMP activity.
Molecular mechanisms of administration of catechins that reduce the neointimal hyperplasia remain largely unknown. We demonstrated EGCG inhibited SMC invasion through upregulation TIMP-2 expression to modulate MMP activity. These findings provide new insights into the mechanisms of action of EGCG as restenosis-preventive agent.
Key Words: smooth muscle cell • migration • matrix metalloproteinase • catechins
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Several epidemiologic and experimental observations have confirmed that there is a close relationship between green tea consumption and cardiovascular disease.1–3 These effects have been largely attributed to the most prevalent polyphenol contained in green tea, epigallocatechin gallate (EGCG). Additionally, recent experiments suggest that green tea catechins reduce atherosclerotic lesions in various animal models of hyperlipidemia.3–6 Although the precise mechanisms are not yet clear, it has been postulated that flavonoids such as EGCG may act as scavengers of reactive oxygen species, thereby preventing the pathogenesis of cardiovascular disease.3–6
Because vascular smooth muscle cells (SMCs) in the large vessels are usually surrounded by and embedded in extracellular matrix (ECM) proteins, the migration of SMCs and the remodeling of tissues during the intimal thickening require controlled degradation of the ECM.7 It is known that SMCs can produce proteolytic enzymes such as matrix metalloproteinases (MMPs), which are a family of zinc-dependent proteinases involved in the degradation and remodeling of the connective tissue.7–10 The data from our groups and others showed that, among MMPs, MMP-2 is most frequently overexpressed in the carotid artery after injury, and that MMP-2 deficiency impaired neointimal formation.7,9 The activation of MMP-2 is in fact one of the crucial steps of the enzymatic cascade leading to ECM degradation. Like other MMPs, MMP-2 is produced as pro–MMP-2 and requires activation to perform its activity,8,10 although MMP-2 has a peculiar pathway of pro–MMP-2 activation initiated by membrane type 1-MMPs (MT1-MMP)10 and urokinase (urokinase plasminogen activator [uPA]).11
It has been reported that uPA, one of the hydrolases implicated in the degradation of ECM and cell invasion, is directly inhibited by EGCG.12 However, the effective concentration of EGCG seems to be too high for it to be physiologically relevant in the tea drinker.13
We recently reported that the administration of green tea catechins suppressed the neointimal hyperplasia in a rat carotid arterial injury model.14 In the study we assumed that the ingestion of catechins inhibits the neointimal formation by shifting the proteolytic balance toward the anti-proteolytic state in the injured vascular wall, resulting in the inhibition of SMC migration from the media into the subendothelial space, although no direct evidence of this has been observed. However, the exact molecular mechanisms of the inhibitory effect of green tea catechins on SMC migration remain unknown. In present study, we tried to demonstrate the mechanisms by which EGCG inhibits SMC invasion through a type I collagen barrier using an in vitro cultured system.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Cell Culture
Cell culture section is described in the online data supplement available at http://atvb.ahajourals.org.
Migration and Invasion Assay
SMC migration and invasion were assessed with a modified Boyden chambers as previously described.8
MT1-MMP–Dependent Pro–MMP-2 Activation Assay
To study the effect of EGCG on MT1-MMP–dependent pro–MMP-2 activation, human recombinant pro–MMP-2 (0.5 µg/mL; Oncogene) was incubated with human recombinant MT1-MMP catalytic domain (MT1-MMPcat, 15 µg/mL; Chemicon International, Inc) in reaction buffer (50 mmol/L Tris-HCl, 150 mmol/L NaCl, 20 mmol/L CaCl2, pH 7.5) with or without catechins at the indicated concentrations for 4 hours at 37°C. The results were analyzed by gelatin zymography (n=5).
Quantitative Real-Time RT-PCR
Quantitative real-time RT-PCR was performed using Assay-on-Demand and ABI PRISM 7700 Sequence Detection System on human targeted genes, MMPs (MMP-1, -2, -9, -13, and MT1-MMP), TIMP-2, and lamin A/C (assay IDs Hs00233958_m1, Hs00234422_m1, Hs00234579_m1, Hs00233992_m1, Hs00237119_m1, Hs00234278_m1, and Hs00153462_m1; Biosystems) as previously described.14
Attachment Assay
After pretreatment with an increasing concentration of EGCG (0 to 10 µmol/L) for 30 minutes, SMC attachment assay was performed as previously described.8
Zymography
Gelatinase activity was detected in the SMC-conditioned media and lysates as previously described.15 Reverse zymography was used to detect activity of TIMP-2 in conditioned media as previously described.16 Equal amount of each sample was loaded for gelatin zymographic (25 µg/line) and reverse zymographic assays (60 µg/line).
To study the effect of EGCG on MT1-MMPcat collagenolytic activities, aliquots of MT1-MMPcat (75 ng/line) were loaded onto a 10% SDS-polyacrylamide gel containing nature type I collagen (1 mg/mL) as substrate (n=5). After electrophoresis, the gels were washed and the separated lanes were developed in the presence of increasing amounts of EGCG (0 to 10 µmol/L) at 37°C.
Transient Transfections
Equimolar amounts of DNA were transiently transfected into human SMCs for 24 hours using Roche Fugene transfection reagent (Amersham Biosciences KK) following the manufacturer’s protocol. The specific gene-knockdown effect of TIMP-2 siRNA oligonucleotide was examined by comparing the reduction in TIMP-2 for siRNA and non-targeting siRNA. The siRNA for lamin A/C was used as positive control. The siCONTROL Non-targeting siRNA oligo (D0012100105), siGENOME SMARTpool TIMP-2 siRNA oligo (M011793000005), and siCONTROL lamin A/C oligos (D0010500105, 3 from Dharmacon, Inc) were separately transfected into human SMCs cytoplasm and the TIMP-2 and lamin A/C were detected by RT-PCR. The lamin A/C was reduced in the lamin A/C siRNA oligo-transfected cells (data not shown).
Western Blotting
The levels of TIMPs and MMPs proteins as above were determined by Western blot in the SMC-conditioned media and lysates as previously described.14,15 Antibodies against for MT1-MMP, TIMP-1, TIMP-2 (3 from Sigma-Aldrich), MMP-2 (Fuji Chemical Co), MMP-9 (Santa Cruz Biotechnology, Inc), and MMP-13 (Neo Markers) were used. Each time this procedure was done, we prepared 2 gels, 1 for Western blot analysis and 1 for Coomassie blue staining, to check the loading of protein as the same amounts.
Statistical Analysis
All data included in the present text were considered to be normally distributed and are presented as mean±SD unless otherwise indicated. Significant differences were analyzed by using Student t test or ANOVA followed by Scheffe multiple comparison post-hoc test. A value of P<0.05 was considered to be statistically significant.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Effects of Catechins on SMC Adhesion, Migration, and Invasion
Green tea catechins that contain the galloyl group in the 3-position in the catechin structure, namely EGCG and ECG, significantly suppressed SMC invasion through a thick layer of collagen lattice, whereas little or no effect was observed with other polyphenols such as EC, C, or EGC (Figure 1A). GA alone also produced no effect (Figure 1A). Moreover, neither green tea catechins nor GA suppressed SMC migration across a filter lightly coated with type I collagen (Figure 1A). As shown in Figure 1B, the invasive activity of SMCs through the type I collagen lattice toward a chemoattractant was restrained by EGCG in a concentration-dependent manner with a minimum detected effect even at 0.1 µmol/L.
|
To establish the involvement of adhesion in the effect of EGCG on SMC invasion, SMCs pretreated with an increasing concentration of EGCG (0 to 10 µmol/L) were adhered to native or denatured type I collagen. No difference in the morphology and the number of attached cells was observed between native and denatured collagen (Figure 1C and 1D). As shown in Figure 1C and 1D, SMC attachment and spreading were significantly inhibited on the denatured collagen at the high dose of EGCG (3 and 10 µmol/L). However, no significant effect of EGCG was detected on SMC attachment and spreading on nature type I collagen (Figure 1C and 1D).
Effects of EGCG on MT1-MMP–Dependent Pro-MMP2 Activation, MT1-MMP Activation, and TIMP-1 and -2 Expression
Our previous study suggested that the primary MMP derived from SMCs in an invasion assay is MMP-2 but not MMP-9.8 As in that previous work, we observed that both pro- and active forms of MMP-2 but not MMP-9 were detected in the conditioned media and lysate from cultured SMCs assessed by gelatin zymographic and Western blotting assays (data not shown). Gelatin zymographic analysis of the conditioned medium from invasion assays revealed that EGCG attenuated pro–MMP-2 conversion into a 64-kDa active form of MMP-2 in a concentration-dependent manner (0.3 to 3 µmol/L; Figure 2A). As shown in Figure 2A, we also observed that EGCG suppressed total gelatinolytic activity in a concentration-dependent manner. We further analyzed the effect of EGCG on the production of MMP-2 by SMCs. As shown Figure 2B and 2C, EGCG did not affect total MMP-2 production even at 10 µmol/L, but it blocked the conversion of pro–MMP-2 into the active form in cultured SMC-conditioned medium. Similarly, the data from Western blotting analysis of the lysate showed that 10 µmol/L of EGCG did not affect MMP-2 and MT1-MMP production (data not shown).
|
Recent evidence has suggested that MT1-MMP activation itself is required to perform pro–MMP-2 activation.17 We next examined whether EGCG affects Concanavalin A (Con-A)–induced MT1-MMP activation in SMCs. As shown in Figure 2D, EGCG had no effect on the Con-A–induced MT1-MMP activation of SMCs compared with the control SMC. To investigate whether EGCG directly inhibits MT1-MMP–dependent pro–MMP-2 activation, recombinant pro–MMP-2 was mixed with recombinant MT1-MMPcat and then incubated with catechins. Gelatin zymographic analysis revealed that the incubation of pro–MMP-2 with MT1-MMPcat yielded bands at 68 and 64 kDa, which seem to correspond to the intermediate and mature form of MMP-2 (Figure 3A). Again EGCG attenuated total gelatinolytic activity in a concentration-dependent manner (Figure 3A). In addition, EGCG significantly inhibited MT1-MMPcat–dependent pro–MMP-2 activation in a concentration-dependent manner with a minimum detected even at 0.3 µmol/L (Figure 3A). ECG was also able to suppress MT1-MMPcat–dependent pro–MMP-2 activation, although other catechins had no effect (Figure 3B).
|
Analysis of the levels of TIMP-1 and TIMP-2 proteins in the conditioned media from an invasion assay revealed that EGCG significantly increased the TIMP-2 level in a concentration-dependent manner with a minimum detected at 0.1 µmol/L (Figure 4A) but had no effect on TIMP-1 (data not shown). Consistently, reverse zymography revealed TIMP-2 activity also increased in conditioned media from an invasion assay in a concentration-dependent manner (Figure 4B). When SMCs were cultured in serum-free medium with or without EGCG for 24 hours, the level of TIMP-2 protein was upregulated by EGCG not only in cultured medium but also in the lysates from cultured SMCs in a concentration-dependent manner (data not shown).
|
Effect of Transfection Using TIMP-2 siRNA on SMC Invasion
The 83% reduction of TIMP-2 mRNA levels was observed in the TIMP-2 siRNA oligo-transfected human SMCs (Figure 4C). As shown in Figure 4D, the impaired invasion ability of SMCs treated with 3 µmol/L of EGCG was significantly recovered by the reduction of TMP-2 mRNA using TIMP-2 siRNA, although no significant difference of SMC invasive activity was detected without EGCG between control and TIMP-2 siRNA-treated SMCs. It should be noted that TIMP-2 siRNA treatment completely recovered the reduction of SMC invasion by ECGC at 0.3 µmol/L (Figure 4D).
Effects of EGCG on MMP-13 Expression and Activation in SMCs
It has recently been reported that SMCs are able to produce MMP-13 and that MMP-13 possesses a potential property for degrading collagen.7,18 The Western blotting data of the conditioned medium from the cultured SMCs showed that the high concentration of EGCG (10 µmol/L) significantly inhibited the production and activation of MMP-13, whereas no change was detected at the low concentration of EGCG (0.3 to 3 µmol/L) (Figure 5A and 5B). It is likely that the inhibitions of MMP-13 activation and expression would be insufficient to bring about SMC invasion suppression by EGCG at the physiological plasma concentration.13 We also observed that EGCG at low concentration (1 to 3 µmol/L) had no effect on the expression of MMP-1, -2, -13, and MT1-MMP mRNA (data not shown). It is consistent with the results of Western blotting analysis of their proteins in the SMC-conditioned media and lysates that EGCG at low concentration did not affect production of MMPs proteins (data not shown). It should be noted that only low level of MMP-9 mRNA was detected in cultured SMCs.
|
Effects of EGCG on MT1-MMP Collagenolytic Activity
The data from the collagen zymographic assay showed that EGCG was able to significantly inhibit the collagenolytic activity of MT1-MMPcat with a minimum detected effect at 0.3 µmol/L (Figure 5C).
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
As revealed by the invasion assay, green tea catechins that have the 3-galloyl group, EGCG and ECG, suppress SMC invasion at a physiological concentration as low as 0.1 µmol/L EGCG, whereas little or no effect is observed with EC, C, EGC, or GA. These findings, which suggest that the galloyl group in the 3-position in catechin structure is necessary for the inhibitory effect on SMC invasion, are in agreement with previous observations of tumor cell invasion in the same range of concentrations.15 The present work revealed that EGCG had no effects on SMC adhesion to the native and denatured type I collagen at the low concentration of EGCG. Taken together with the observation that neither green tea catechins nor GA suppressed SMC migration, it is suggested that the inhibitory effect of EGCG on SMC invasion is not attributable to the cell adhesion and motility impairment but rather to the inhibition of proteinases derived from SMCs, at least at the physiological concentrations of EGCG that we used.
A number of studies have shown that among MMPs, MMP-9 is expressed in injured arterial walls only in the early phase after injury, that MMP-2 is expressed constitutively in a latent form in the arterial wall and overexpressed in an activated form during the period from 5 to 14 days after injury, and that MMP-2 deficiency significantly reduced neointimal hyperplasia.7,9,14 In the present work we observed that both pro- and active-form MMP-2 but not MMP-9 were produced in the conditioned medium and lysates on the basis not only of an SMC invasion assay but also of cultured SMCs, a finding that is consistent with our previous findings.8 However, the data from our and other groups’ studies indicated that MMP-9 may be namely secreted by infiltrated inflammatory cells at early period after the injury and plays an important role for atherosclerotic lesion and neointimal formation.9,14,20,21 We previously demonstrated that the inclusion of MMP inhibitors blocked SMC invasion in accompaniment with the inhibition of pro–MMP-2 activation.8 These findings indicate that the activated MMP-2 plays a fundamental role in SMC invasion. Based on these observations, we conclude that MMP-2 is one of the most essential MMPs involved in the invasive behavior of SMCs through type I collagen barrier.
We and others previously demonstrated that EGCG inhibits MMP-2 activity even at physiological concentrations of EGCG.13,15,19 We also observed that EGCG binds to pro- as well as the mature form of MMP-2, leading to reversible conformational changes in MMP-2 molecules or to masking the catalytic region of MMP-2, either of which may be essential for proteolytic activity.15 The EGCG–MMP-2 complex is not dissociated during the zymographic analysis, resulting in the inhibition of the gelatinolytic activity of MMP-2 pretreated with EGCG in gelatin zymography. In the present study we confirmed that the treatment of MMP-2 with EGCG attenuated its gelatinolytic bands in a concentration-dependent manner. On the other hand, the activation of pro–MMP-2 by MT1-MMP is thought to represent a crucial step in tumor invasion and metastasis.10,22 In gliomas, particularly, MT1-MMP–dependent pro–MMP-2 activation has been strongly correlated with glioma invasiveness.23 These findings led us to investigate the effect of green tea catechins on MT1-MMP–dependent pro–MMP-2 activation in SMCs during their invasive process. In the present study, we clearly demonstrated that EGCG blocks the activation of SMC-derived pro–MMP-2 during SMC invasion and the culture of SMCs. It should be noted that EGCG was found to have no effect on Con-A–induced MT1-MMP activation in SMCs. A large number of studies have shown that EGCG inhibits MMPs expression including MMP-1, -2, -9, and MT1-MMP in various cell types.24,25 However, the effective concentrations of EGCG seem to be too high for it to be physiologically relevant for tea drinkers. In fact, EGCG at low concentration (1 to 3 µmol/L) had no effect on the expression of MMPs (MMP-1, -2, -13, and MT1-MMP). Overall, these results suggest that modulation of MMP expression is not a like mechanism for the inhibitory effect of EGCG on SMC invasion at the concentration of EGCG similar to those in the plasma of moderate green tea drinkers (
0.1 to 0.3 µmol/L).13
In addition, Western blot and reverse zymography data revealed that EGCG significantly stimulated the production of TIMP-2 protein in SMCs during their invasion process and cultured SMC but had no effect on TIMP-1, a finding that is consistent with our previous finding that the administration of green tea catechin upregulates TIMP-2 levels in the balloon injured carotid arteries.14 As sufficient amounts of TIMP-2 specifically inhibit both MMP-2 gelatinolytic activity and pro–MMP-2 activation by MT1-MMP,8,23 it is possible that EGCG inhibits not only MMP-2 gelatinolytic activity but also its transformation into an activated form of MMP-2 through TIMP-2 upregulation. Additionally, we clearly showed that EGCG directly blocks MT1-MMPcat–dependent pro–MMP-2 activation, suggesting a possible mechanism whereby the influence of EGCG on SMC invasion is mediated by the inhibition of MT1-MMP–dependent pro–MMP-2 activation via its direct effect on MT1-MMP activity. This hypothesis is supported by the present finding that, in collagen zymographic analysis, EGCG inhibited MT1-MMP activity. Given that EGCG inhibits the gelatinolytic activity of mature MMP-2, there are 3 possible mechanisms by which EGCG inhibits MMP-dependent SMC invasion through the fibrillar collagen barrier (Figure I, available online at http://atvb.ahajourals.org). First, it is possible that EGCG directly inhibits the gelatinolytic activity of MMP-2 and the collagenolytic activity of MT1-MMP; second, EGCG may directly block MT1-MMP–dependent pro–MMP-2 transformation into an active form of MMP-2 without the influence of MT1-MMP activation but via the inhibition of MT1-MMP activity; and third, EGCG may inhibit MMP-2 gelatinolytic activity and pro–MMP-2 activation through TIMP-2 upregulation in SMCs. In fact, we clearly showed that the reduction of TIMP-2 mRNA using TIMP-2 siRNA recovered the inhibitory effect of EGCG on SMC invasive behavior, and especially TIMP-2 siRNA treatment completely recovered the effect of low concentration of EGCG (0.3 µmlo/L). These results suggest that the third one may be one of the major effects of EGCG, at least at the physiological concentration of EGCG.
In this report, we demonstrated that EGCG inhibited the invasion of SMC through a type I collagen barrier via the modulation of MT1-MMP–dependent pro–MMP-2 activation and upregulation of TIMP-2 expression and directly inhibition of MMP-2 and MT1-MMP. These findings thus emphasize the pleiotropic activity of EGCG on intracellular MMP-mediated events and may provide new insights into the mechanisms of action of EGCG and green tea extract as atherosclerosis- and restenosis-preventive agents in humans. Drinking green tea daily would contribute to maintaining plasma catechin levels sufficient to exert pharmacological effects.13 Increasing evidence suggest that clinical trials of catechins for arterial remodeling such as neointimal formation after angioplasty is expected to be carried out in the near future.
Received January 30, 2005; accepted July 13, 2005.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
- Hertog MG, Feskens EJ, Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet. 1997; 349: 699.[Medline] [Order article via Infotrieve]
- Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993; 342: 1007–1011.[CrossRef][Medline] [Order article via Infotrieve]
- Tijburg LB, Mattern T, Folts JD, Weisgerber UM, Katan MB. Tea flavonoids and cardiovascular disease. Crit Rev Food Sci Nutr. 1997; 37: 771–785.[Medline] [Order article via Infotrieve]
- Miura Y, Chiba T, Tomita I, Koizumi H, Miura S, Umegaki K, Hara Y, Ikeda M, Tomita T. Tea catechins prevent the development of atherosclerosis in Apoprotein E-deficient mice. J Nutr. 2001; 131: 27–31.
[Abstract/Free Full Text] - Chyu KY, Babbidge SM, Zhao X, Dandillaya R, Rietveld AG, Yano J, Dimayuga P, Cercek B, Shah PK. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation. 2004; 109: 2448–2453.
[Abstract/Free Full Text] - Hayek T, Fuhrman B, Vaya J, Rosenblat M, Belinky P, Coleman R, Elis A, Aviram M. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol. 1997; 17: 2744–2752.
[Abstract/Free Full Text] - Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 1994; 75: 539–545.
[Abstract/Free Full Text] - Kanda S, Kuzuya M, Ramos MA, Koike T, Yoshino K, Ikeda S, Iguchi A. Matrix metalloproteinase and
vß3 integrin-dependent vascular smooth muscle cell invasion through a type I collagen lattice. Arterioscler Thromb Vasc Biol. 2000; 20: 998–1005.[Abstract/Free Full Text] - Kuzuya M, Kanda S, Sasaki T, Tamaya-Mori N, Cheng XW, Itoh T, Itohara S, Iguchi A. Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia. Circulation. 2003; 108: 1375–1381.
[Abstract/Free Full Text] - Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994; 370: 61–65.[CrossRef][Medline] [Order article via Infotrieve]
- Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, Mignatti P. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J. 1997; 16: 2319–2332.[CrossRef][Medline] [Order article via Infotrieve]
- Jankun J, Selman SH, Swiercz R, Skrzypczak-Jankun E. Why drinking green tea could prevent cancer. Nature. 1997; 387: 561.[CrossRef][Medline] [Order article via Infotrieve]
- Yang CS, Wang ZY. Tea and cancer. J Natl Cancer Inst. 1993; 85: 1038–1049.
[Abstract/Free Full Text] - Cheng XW, Kuzuya M, Sasaki T, Kanda S, Tamaya-Mori N, Koike T, Maeda K, Nishitani E, Iguchi A. Green tea catechins inhibit neointimal hyperplasia in a rat carotid arterial injury model by TIMP-2 overexpression. Cardiovasc Res. 2004; 62: 594–602.
[Abstract/Free Full Text] - Cheng XW, Kuzuya M, Kanda S, Maeda K, Sasaki T, Wang QL, Tamaya-Mori N, Shibata T, Iguchi A. Epigallocatechin-3-gallate binding to MMP-2 inhibits gelatinolytic activity without influencing the attachment to extracellular matrix proteins but enhances MMP-2 binding to TIMP-2. Arch Biochem Biophys. 2003; 415: 126–132.[CrossRef][Medline] [Order article via Infotrieve]
- Fabunmi RP, Baker AH, Murray EJ, Booth RF, Newby AC. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem J. 1996; 315: 335–342.
- Belien AT, Paganetti PA, Schwab ME. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J Cell Biol. 1999; 144: 373–384.
[Abstract/Free Full Text] - Creemers EE, Cleutjens JP, Smits JF, Daemen MJ. Matrix metalloproteinase inhibition after myocardial infarction:a new approach to prevent heart failure? Circ Res. 2001; 89: 201–210.
[Abstract/Free Full Text] - Garbisa S, Sartor L, Biggin S, Salvato B, Benelli R, Albini A. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer. 2001; 91: 822–832.[CrossRef][Medline] [Order article via Infotrieve]
- Lijnen HR, Van Hoef B, Lupu F, Moons L, Carmeliet P, Collen D. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol. 1998; 18: 1035–1045.
[Abstract/Free Full Text] - Luttun A, Lutgens E, Manderveld A, Maris K, Collen D, Carmeliet P, Moons L. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation. 2004; 109: 1408–1414.
[Abstract/Free Full Text] - Nakahara H, Howard L, Thompson EW, Sato H, Seiki M, Yeh Y, Chen WT. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci U S A. 1997; 94: 7959–7964.
[Abstract/Free Full Text] - Zhao H, Bernardo MM, Osenkowski P, Sohail A, Pei D, Nagase H, Kashiwagi M, Soloway PD, DeClerck YA, Fridman R. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation. J Biol Chem. 2004; 279: 8592–8601.
[Abstract/Free Full Text] - Yun JH, Pang EK, Kim CS, Yoo YJ, Cho KS, Chai JK, Kim CK, Choi SH. Inhibitory effects of green tea polyphenol (–)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts. J Periodontal Res. 2004; 39: 300–307.[CrossRef][Medline] [Order article via Infotrieve]
- Ahmed S, Wang N, Lalonde M, Goldberg VM, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther. 2004; 308: 767–773.
[Abstract/Free Full Text]
This article has been cited by other articles:
 |
|
 |
|
  V. Stangl, H. Dreger, K. Stangl, and M. Lorenz Molecular targets of tea polyphenols in the cardiovascular system Cardiovasc Res, January 15, 2007; 73(2): 348 - 358. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||